Navigation Links
Amsterdam Molecular Therapeutics Reports Full Year Results 2007
Date:2/19/2008

d by law. For a more detailed description of the risk factors and uncertainties affecting AMT, refer to the prospectus of AMT's initial public offering on June 20, 2007, and AMT's public announcements made from time to time.

Consolidated income statement

(In EUR x 1,000)

Year ended

31 December 2007 31 December 2006

Revenues - 52

Cost of sales - 42

Gross profit - 10

Other income 110 417

Total net income 110 427

Research and development costs (9,804) (5,342)

General and administrative costs (4,966) (4,169)

Total operating costs (14,770) (9,511)

Operating result (14,660) (9,084)

Interest income 1,406 14

Interest costs (1,681) (803)

(275) (789)

Result on deconsolidation - 1,113

Result before corporate income taxes (14,935) (8,760)

Corporate income taxes - -

Result for the year (14,935) (8,760)

Attributable to:

Equity holders of the Company (14,935) (8,760)

Result attributable to equity holders is

split as follows:

Ordinary shareholders
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
2. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
3. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
4. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
5. Acrongenomics on Track to Acquire Molecular Vision
6. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
7. Acrongenomics Acquires Equity Stake in Molecular Vision
8. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
9. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
10. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
11. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... for cells and tissues  ("BioLife" or the "Company"), today ... Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... Earlier this year in a June 24 international conference ... Cell Technology Center, LLC ( ASCTC ) focused attention on ... tissue stem cells. His title “Asymmetric Self-Renewal by Distributed ... embodied the essence of his message to congress participants. ...
(Date:12/24/2014)... According to Ross Selinger, President of ... Global, the national office market continues to be strong, driven ... evidenced by the third quarter’s surprising 3.9% GDP, unemployment decreasing ... costs have held inflation down and the Fed is keeping ...
(Date:12/24/2014)... The report expects global cell isolation and expansion ... a carefully analyzed data about the vital drivers, restraints, trends, ... of Report @ http://bit.ly/1yUxy0T , According to the ... growth at an impressive CAGR during near future. It expects ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... R&D Directions honors Dr. Sellers, pioneering work in human ... KNDL ), a leading, global full-service clinical research ... and General Manager of the company,s Early Stage Unit ... People in R&D" by leading industry publication R&D ...
... March 26 MacroGenics, Inc., a privately held biotechnology ... and infectious diseases, today announced the appointment of Eric ... very pleased that we have been able to attract ... MacroGenics," said Dr. Scott Koenig, President and CEO. ...
... Md., March 26 Novavax, Inc. (Nasdaq: NVAX ... quarter financial results in a press release to be issued ... Company will hold an investor conference call to discuss its ... 2009. The call will be hosted by Novavax President and ...
Cached Biology Technology:Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine 'Notable People in R&D' 2Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine 'Notable People in R&D' 3MacroGenics Appoints New Vice President of Business Development 2MacroGenics Appoints New Vice President of Business Development 3Novavax Announces New Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call 2Novavax Announces New Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call 3
(Date:12/17/2014)... Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced the ... report to their offering. ... in this market is the increasing demand for medical ... of patient data for quick and correct diagnosis during ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. One major ... multimodal biometric systems. Multimodal biometric systems utilize more than ...
(Date:12/10/2014)... a leader in performance biometric data sensor technology, today ... licensees for highly accurate, clinically validated biometric technology. This ... fitness and health sectors, but first responders/military and gaming ... as useful as the biometric data it delivers. As ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... lotion which glows under ultraviolet light have shown that ... properly cleaned. Their findings, published in BioMed Centrals journal, ... nasty bacteria Clostridium difficile (C. difficile) linger in the ... Michelle Alfa and a team of scientists from ...
... by ... providing volunteer coaching, SOUTHFIELD, Mich., May 9 The Center ... Moore, one of,its examiners, as a volunteer coach for trainees working ... been with the CCF for 3 years, will lend his 8 ...
... ... the platypus is one odd duck-billed, egg-laying, lactating ... aquatic lifestyle and the poison spurs that decorate males, ... development. But LSUs Mark Batzer, along with an international ... University in Saint Louis, Mo., has taken this theory ...
Cached Biology News:UV lotion lights the way to cleaner facilities 2Center for Computer Forensics Offers Expert to Volunteer as CFCE Certification Applicants Coach 2First analysis of platypus genome may impact disease prevention 2
GOAT ANTI HUMAN PARAINFLUENZA VIRUS 2+3...
75 x 25 mm; sterile, recommended for immunohistochemistry of cell lines growing in suspension, Poly-D-Lysine coated, glass slides with polystyrene vessel, lid and safety removal tool...
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
IMAGEQUANT 300 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: